PAG
ARKG icon

Paladin Advisory Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Paladin Advisory Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-400
Closed -$11.3K – 286
2022
Q4 		$11.3K Hold
400
– – 0.01% 212
2022
Q3 		$13K Hold
400
– – 0.01% 215
2022
Q2 		$12K Buy
+400
New +$14K 0.01% 218
2022
Q1 		– Sell
-400
Closed -$24K – 297
2021
Q4 		$24K Buy
+400
New +$27.7K 0.02% 207

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Paladin Advisory Group's ARKG Position: Q1 2026 in Review

Paladin Advisory Group held its ARK Genomic Revolution ETF (ARKG) position steady in Q1 2026 at 400 shares worth $10.6K. The position accounts for 0.01% of the portfolio, ranked #204.

Paladin Advisory Group first reported a position in ARKG in Q1 2022 and has held it in 14 quarters since. The position peaked at $19K in Q1 2022. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Paladin Advisory Group held 400 shares of ARK Genomic Revolution ETF worth $10.6K as of Q1 2026.
  • Paladin Advisory Group left its ARK Genomic Revolution ETF share count unchanged in Q1 2026.
  • ARK Genomic Revolution ETF made up 0.01% of Paladin Advisory Group's portfolio in Q1 2026, its #204 holding.
  • Paladin Advisory Group first reported a position in ARK Genomic Revolution ETF in Q1 2022 and has held it in 14 quarters since.
  • Paladin Advisory Group's ARK Genomic Revolution ETF position peaked at $19K in Q1 2022.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Paladin Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.